跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
New Ambiceph - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
New Ambiceph
Approved
STANDARD
New Ambiceph
Innova Captab Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
bd2675e4ee5609e3
Company
Innova Captab Limited
Type
Standard
Approval Details
Approval Id
bd2675e4ee5609e3
Drug Approval Philippines Name
New Ambiceph
Product Name
New Ambiceph
Registration Number
DRP-3242-04
Brand Name
New Ambiceph
Generic Name
Ceftriaxone (as Sodium)
Dosage Form
Powder for Injection (IM/IV)
Dosage Strength
1 g
Manufacturer
Innova Captab Limited
Trader
Virchow Healthcare Private Limited
Importer
Ambica International Corp
Distributor
Pharmalife Distribution
Issuance Date
25 September 2024
Expiry Date
08 February 2028
Pharmacologic Category
Antibacterial (3rd Generation Cephalosporin)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
bd2675e4ee5609e3
Type
Standard
Back to Philippines FDA Approvals